Per Johansson - Karo Pharma Insider

KARBF -- USA Stock  

USD 4.00  0.45  12.68%

Mr. Per Anders Johansson has served as Independent Member of the Board of Directors at Karo Bio AB since June 12 2012. He is also Chief Executive Officer and Chairman of CIMON and Chairman of the Savings bank in Karlshamn. He is Founder of the technical consulting company CIMON AB as well as Chief Financial Officer and Vice President of Ellos Nordico and the Karlshamn Group.
Age: 60  Executive Since 2012      
46 1 03 30 23 10

Management Efficiency

The company has return on total asset (ROA) of 1.81 % which means that it generated profit of $1.81 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 1.26 % meaning that it generated $1.26 on every $100 dollars invested by stockholders.
The company has accumulated 293.75 M in total debt with debt to equity ratio (D/E) of 155.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karo Pharma AB has Current Ratio of 1.09 suggesting that it may not be capable to disburse its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Karo Pharma AB , a healthcare company, develops and markets products for elderly people in Sweden, Norway, Denmark, and Finland. Karo Pharma AB was founded in 1987 and is based in Stockholm, Sweden. Karo Pharma is traded on OTC Market in USA.Karo Pharma AB (KARBF) is traded on OTC Market in USA. It is located in Nybrokajen 7 and employs 39 people.

Karo Pharma AB Leadership Team

PerAnders Johansson, Independent Director
Jean Lycke, Director
Per Johansson, Member of the Board
Peter Blom, CEO
Henrik Palm, CFO
Anders Lonner, Chairman of the Board
Marianne Hamilton, Director
Maria Sjoberg, Vice President Chief Scientific Officer, responsible for Preclinical Research and Development
Hakan Astrom, Director
Thomas Kraft, Country Manager Norway
Goran Wessman, Director
Bo Carlsson, Member of the Board, Employee Representative
Thomas Hedner, Director

Stock Performance Indicators

Current Sentiment - KARBF

Karo Pharma AB Investor Sentiment
Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Karo Pharma AB. What is your trading attitude regarding investing in Karo Pharma AB? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.